{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:44:52Z","timestamp":1793245492139,"version":"4.5.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,10,26]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Npm1c and Nras-G12D co-mutation in mice leads to AML with a longer latency and a more mature phenotype than the Npm1c\/Flt3-ITD combination. Mutant Flt3 or Nras allele amplification is the dominant mode of progression in both Npm1c\/Flt3-ITD and Npm1c\/Nras-G12D murine AML.<\/jats:p>","DOI":"10.1182\/blood-2017-01-760595","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T21:00:18Z","timestamp":1503522018000},"page":"1911-1922","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":94,"title":["Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia"],"prefix":"10.1182","volume":"130","author":[{"given":"Oliver M.","family":"Dovey","sequence":"first","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Mupo","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.","family":"Grove","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"},{"name":"School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia;"},{"name":"PathWest Division of Clinical Pathology, Queen Elizabeth II Medical Centre, Nedlands, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lynn","sequence":"additional","affiliation":[{"name":"Leukemia and Stem Cell Biology Group, Division of Cancer Studies, Department of Haematological Medicine, King's College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Conte","sequence":"additional","affiliation":[{"name":"Sample Phenotype Ontology Team, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Andrews","sequence":"additional","affiliation":[{"name":"Institute of Translation, Innovation, Methodology, and Engagement, Cardiff University School of Medicine, Cardiff, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suruchi","family":"Pacharne","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tzelepis","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Vijayabaskar","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Green","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Rad","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Klinikum Rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany;"},{"name":"German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Arends","sequence":"additional","affiliation":[{"name":"Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Yusa","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Bradley","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Varela","sequence":"additional","affiliation":[{"name":"Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-8022","authenticated-orcid":false,"given":"George S.","family":"Vassiliou","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;"},{"name":"Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"22","key":"2019111904212462900_B1","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"issue":"23","key":"2019111904212462900_B2","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111904212462900_B3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111904212462900_B4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"issue":"4","key":"2019111904212462900_B5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ccr.2007.08.031","article-title":"FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia","volume":"12","author":"Lee","year":"2007","journal-title":"Cancer Cell"},{"issue":"6","key":"2019111904212462900_B6","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood-2010-04-280750","article-title":"Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus","volume":"117","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019111904212462900_B7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/ng.796","article-title":"Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice","volume":"43","author":"Vassiliou","year":"2011","journal-title":"Nat Genet"},{"issue":"9","key":"2019111904212462900_B8","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/leu.2013.77","article-title":"A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice","volume":"27","author":"Mupo","year":"2013","journal-title":"Leukemia"},{"issue":"11","key":"2019111904212462900_B9","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/leu.2013.114","article-title":"NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model","volume":"27","author":"Mallardo","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"2019111904212462900_B10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/leu.2014.257","article-title":"Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications","volume":"29","author":"Sportoletti","year":"2015","journal-title":"Leukemia"},{"issue":"4","key":"2019111904212462900_B11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","article-title":"A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia","volume":"17","author":"Tzelepis","year":"2016","journal-title":"Cell Reports"},{"issue":"8","key":"2019111904212462900_B12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","article-title":"Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis","volume":"10","author":"McKerrell","year":"2015","journal-title":"Cell Reports"},{"issue":"1","key":"2019111904212462900_B13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2015-11-683334","article-title":"Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies","volume":"128","author":"McKerrell","year":"2016","journal-title":"Blood"},{"issue":"7478","key":"2019111904212462900_B14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nature12830","article-title":"Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness","volume":"504","author":"Li","year":"2013","journal-title":"Nature"},{"issue":"26","key":"2019111904212462900_B15","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1182\/blood-2012-12-475863","article-title":"Nras(G12D\/+) promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2019111904212462900_B16","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.celrep.2013.04.031","article-title":"FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors","volume":"3","author":"Mead","year":"2013","journal-title":"Cell Reports"},{"issue":"4","key":"2019111904212462900_B17","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ccell.2015.03.009","article-title":"Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia","volume":"27","author":"Shih","year":"2015","journal-title":"Cancer Cell"},{"issue":"6774","key":"2019111904212462900_B18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35004599","article-title":"A clonogenic common myeloid progenitor that gives rise to all myeloid lineages","volume":"404","author":"Akashi","year":"2000","journal-title":"Nature"},{"issue":"25","key":"2019111904212462900_B19","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1182\/blood-2008-12-192054","article-title":"Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential","volume":"113","author":"Kent","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2019111904212462900_B20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/leu.2015.6","article-title":"Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells","volume":"29","author":"Spencer","year":"2015","journal-title":"Leukemia"},{"issue":"9","key":"2019111904212462900_B21","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ng.3371","article-title":"The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias","volume":"47","author":"Lavall\u00e9e","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"2019111904212462900_B22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood.V99.1.121","article-title":"Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion","volume":"99","author":"Thorsteinsdottir","year":"2002","journal-title":"Blood"},{"issue":"1","key":"2019111904212462900_B23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V100.1.238","article-title":"Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice","volume":"100","author":"Kogan","year":"2002","journal-title":"Blood"},{"key":"2019111904212462900_B24","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1038\/bcj.2014.27","article-title":"Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3\/ITD AML","volume":"4","author":"Stirewalt","year":"2014","journal-title":"Blood Cancer J"},{"issue":"9","key":"2019111904212462900_B25","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1073\/pnas.1424400112","article-title":"Mutant IDH is sufficient to initiate enchondromatosis in mice","volume":"112","author":"Hirata","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111904212462900_B26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/leu.2014.149","article-title":"Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies","volume":"29","author":"Weisberg","year":"2015","journal-title":"Leukemia"},{"issue":"7","key":"2019111904212462900_B27","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/onc.2012.110","article-title":"The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia","volume":"32","author":"Shi","year":"2013","journal-title":"Oncogene"},{"issue":"11","key":"2019111904212462900_B28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.exphem.2015.06.005","article-title":"Inactivation of Eed impedes MLL-AF9-mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model","volume":"43","author":"Danis","year":"2015","journal-title":"Exp Hematol"},{"issue":"5","key":"2019111904212462900_B29","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2003-07-2582","article-title":"Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia","volume":"103","author":"Kumar","year":"2004","journal-title":"Blood"},{"issue":"7370","key":"2019111904212462900_B30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"issue":"10","key":"2019111904212462900_B31","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1158\/2159-8290.CD-16-0237","article-title":"Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia","volume":"6","author":"K\u00fchn","year":"2016","journal-title":"Cancer Discov"},{"issue":"11","key":"2019111904212462900_B32","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.18632\/oncotarget.1306","article-title":"HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia","volume":"4","author":"Brumatti","year":"2013","journal-title":"Oncotarget"},{"issue":"9","key":"2019111904212462900_B33","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/onc.2015.174","article-title":"Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets","volume":"35","author":"Collins","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"2019111904212462900_B34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood-2011-03-341081","article-title":"Identification and characterization of Hoxa9 binding sites in hematopoietic cells","volume":"119","author":"Huang","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2019111904212462900_B35","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.3324\/haematol.2016.146159","article-title":"Identification of a germline F692L drug resistance variant in cis with Flt3-internal tandem duplication in knock-in mice","volume":"101","author":"Dovey","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"2019111904212462900_B36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood-2006-05-024018","article-title":"Activation mechanisms of STAT5 by oncogenic Flt3-ITD","volume":"110","author":"Choudhary","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019111904212462900_B37","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.celrep.2014.10.039","article-title":"Regulation of Stat5 by FAK and PAK1 in oncogenic FLT3- and KIT-driven leukemogenesis","volume":"9","author":"Chatterjee","year":"2014","journal-title":"Cell Reports"},{"issue":"2","key":"2019111904212462900_B38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.celrep.2016.03.018","article-title":"Leukemogenic MLL-ENL fusions induce alternative chromatin states to drive a functionally dichotomous group of target genes","volume":"15","author":"Garcia-Cuellar","year":"2016","journal-title":"Cell Reports"},{"issue":"9","key":"2019111904212462900_B39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1158\/2159-8290.CD-13-0096","article-title":"Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation","volume":"3","author":"Xu","year":"2013","journal-title":"Cancer Discov"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/17\/1911\/1403154\/blood760595.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/17\/1911\/1403154\/blood760595.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T04:21:45Z","timestamp":1574137305000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/17\/1911\/36521\/Molecular-synergy-underlies-the-cooccurrence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":39,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017,10,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-01-760595","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,26]]}}}